University of Illinois at Chicago

News Advisory: UIC-Shakespeare Theater partnership supplies 5,000 masks to UI Health, leads to work for many

Newswise — They used to outfit performers on Chicago’s theater stages, but today costume fabricators from across the city are making patient masks for health care settings in the fight against COVID-19 as part of a new partnership between UIC’s College of Architecture, Design, and the Arts, or CADA, and the Chicago Shakespeare Theater.

This partnership already has resulted in the manufacture of 5,000 face masks, which are to be delivered to University of Illinois Hospital to meet the Centers for Disease Control and Prevention (CDC) recommendation that patients in a health care setting should wear face masks.


Friday, April 3
4 p.m.


UI Hospital
1740 W. Taylor St.


First Lady Amy Eshleman will be on hand, along with Chris Plevin, director of production for the Chicago Shakespeare Theater; Rebecca Rugg, dean of CADA; Dr. Robert Barish, vice chancellor for health affairs, and Shelly Major, chief nursing officer for UI Health, to receive the face masks to help ward off the spread of COVID-19.

With funding from UIC’s leadership, Rugg enlisted CADA faculty and staff, the UIC Innovation in COVID-19 Working Group and the Chicago Shakespeare Theater to design and approve cotton face masks for patients and to pay skilled artists in the theater’s costume shop to fabricate them, with a goal of delivering 250,000 masks to hospitals and convalescence wards throughout the Chicago area.

“The live arts were immediately hit hard by this pandemic,” Rugg said. “Places where people gather became a public health hazard, so productions and theaters were closed, and some nonprofits have needed to lay people off. This felt like a way to help the health system and help the unexpectedly unemployed fabricators in the theater industry.”

Myron Elliott, assistant professor in UIC’s School of Theatre and Music, brought his experience as a costume designer and technician to the design and sourcing of materials for this project. Elliott worked with Dr. Yannek Leiderman, a retinal surgeon who leads the Vitreoretinal Microsurgery Laboratory and part of the UIC Innovation in COVID-19 Working Group, to validate his design and materials with input from the Hospital Incident Command Group and Environmental Health and Safety Office.

Working in a health care setting was a new experience for Elliott, who spent his career in theater costume shops across the city.

“I usually make clothes for imaginary people. But these masks are for real people and do an important job,” he said. “It brought a sense of urgency and pride to my work in a time when I feel a little helpless.”

Materials are a critical concern when it comes to personal protective equipment. According to Leiderman, a surgical mask must accomplish two things: stop the spread of germs from the mouth and nose of a health care worker to a patient, and stop the transmission of germs from patients to the health care worker. It’s important to note that a surgical mask is not the same as a surgical respirator, such as an N95 respirator mask.

Together, the bioengineering and costume design teams settled on a 100 percent cotton, double-layer design.

“As a physician and surgeon, it’s rewarding to be part of a project that is helping our team at UI Health. But as a member of the Chicago community, it’s also very gratifying to help our arts and theater community,” Leiderman said.

Marcia Lausen, director of the UIC School of Design, and Philip Burton, professor and chair of graphic design, created a graphic identity for the project based on their early work to establish a brand identity for Chicago Shakespeare Theater. In the meantime, the Chicago Shakespeare Theater had its costume shop deemed “essential” by the City of Chicago and hired staff to assemble the masks.  

Chicago Shakespeare Theater’s Plevin shared, “Chicago Shakespeare is proud to be partnering with UIC and the Chicago theater community in addressing two critical challenges facing our city in this time of crisis. With the shuttering of our theaters due to COVID-19, swaths of our city’s theater makers have found themselves suddenly and unexpectedly out of work. 

“By rallying this extraordinary team of over 100 costume artisans into producing masks for our medical institutions, we can support the defense of our city against this virus, while offering much-needed employment to the artists of Chicago.”

Paying the fabricators is especially gratifying to Rugg, who said the project takes its inspiration from President Franklin Roosevelt’s Works Progress Administration efforts during the Great Depression, which, in addition to other infrastructure efforts, famously created the Federal Theater Project. Back then, the government paid people to do the work that fit their skills and helped lift the country’s economy.

“When it comes to making sense of this moment, everyone is turning to the arts for connection, for comfort, and for a sense of beauty. The arts are essential in that regard,” Rugg said.

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573